Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for DNTH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 886.81M
March 31, 2026 1.111B
December 31, 2025 404.30M
September 30, 2025 402.61M
June 30, 2025 257.39M
March 31, 2025 263.23M
December 31, 2024 275.24M
September 30, 2024 281.12M
June 30, 2024 360.71M
March 31, 2024 377.04M
December 31, 2023 173.72M
September 30, 2023 189.87M
June 30, 2023 77.59M
March 31, 2023 79.99M
December 31, 2022 75.49M
September 30, 2022 128.28M
June 30, 2022 139.42M
March 31, 2022 156.60M
Date Value
December 31, 2021 176.93M
September 30, 2021 192.62M
June 30, 2021 207.80M
March 31, 2021 132.29M
December 31, 2020 148.84M
September 30, 2020 161.73M
June 30, 2020 176.50M
March 31, 2020 130.41M
December 31, 2019 145.73M
September 30, 2019 160.57M
June 30, 2019 172.27M
March 31, 2019 127.31M
December 31, 2018 142.57M
September 30, 2018 159.84M
June 30, 2018 173.59M
March 31, 2018 41.63M
December 31, 2017 51.57M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Legend Biotech Corp. 964.63M
Ironwood Pharmaceuticals, Inc. 79.13M
Verastem, Inc. 136.35M
Fortress Biotech, Inc. 196.58M
AbbVie, Inc. 6.569B